PCK1 and neoplasm: As shown in Figure 4B, overexpression of PCK1 significantly reduced the growth rate of MHCC-97H tumor growth compared with the mock and GFP control group by measuring tumor volume every 4 days (*P < 0.05, AdPCK1 group vs. AdGFP group, Figure 4B).